Stayce E Beck
Overview
Explore the profile of Stayce E Beck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castle J, Beck S
J Diabetes Sci Technol
. 2024 Feb;
18(3):741-742.
PMID: 38390844
No abstract available.
2.
Polsky S, Valent A, Isganaitis E, Castorino K, OMalley G, Beck S, et al.
Diabetes Technol Ther
. 2024 Feb;
26(5):307-312.
PMID: 38315503
We evaluated accuracy and safety of a seventh-generation real-time continuous glucose monitoring (CGM) system during pregnancy. Evaluable data for accuracy analysis were obtained from 96 G7 sensors (Dexcom, Inc.) worn...
3.
Laffel L, Bailey T, Christiansen M, Reid J, Beck S
J Diabetes Sci Technol
. 2022 Apr;
17(4):962-967.
PMID: 35466707
Background: Accuracy of a seventh-generation "G7" continuous glucose monitoring (CGM) system was evaluated in children and adolescents with type 1 diabetes (T1D). Methods: Sensors were worn on the upper arm...
4.
Garg S, Kipnes M, Castorino K, Bailey T, Akturk H, Welsh J, et al.
Diabetes Technol Ther
. 2022 Feb;
24(6):373-380.
PMID: 35157505
We evaluated the accuracy and safety of a seventh generation (G7) Dexcom continuous glucose monitor (CGM) during 10.5 days of use in adults with diabetes. Adults with either type 1...
5.
Beck S, Kelly C, Price D
Diabet Med
. 2021 Nov;
39(2):e14739.
PMID: 34758142
Objective: Prior to the Continuous Monitoring and Control of Hypoglycaemia (COACH) study described herein, no study had been powered to evaluate the impact of non-adjunctive RT-CGM use on the rate...
6.
Price D, Deng Q, Kipnes M, Beck S
Diabetes Ther
. 2021 Jun;
12(7):2089-2099.
PMID: 34089138
Introduction: Resistance to initiating insulin therapy is common for people with type 2 diabetes (T2D) using multiple oral agents, resulting in sustained poor glycemic control. We explored a non-pharmacologic option...
7.
Harvey Towers R, Zhang X, Yousefi R, Esmaili G, Wang L, Garcia A, et al.
J Diabetes Sci Technol
. 2021 Apr;
16(5):1224-1227.
PMID: 33855885
The algorithm for the Dexcom G6 CGM System was enhanced to retain accuracy while reducing the frequency and duration of sensor error. The new algorithm was evaluated by post-processing raw...
8.
Peters A, Cohen N, Calhoun P, Ruedy K, Beck R, Martens T, et al.
Diabetes Obes Metab
. 2020 Oct;
23(2):631-636.
PMID: 33118309
Basal insulin is often prescribed to patients with suboptimally controlled type 2 diabetes (T2D); however, its therapeutic efficacy is inadequate in many. During the MOBILE study's baseline phase, we evaluated...
9.
Atmaja B, Lui B, Hu Y, Beck S, Frank C, Cochran J
Adv Funct Mater
. 2015 Mar;
20(23):4091-4097.
PMID: 25750609
We report a highly tunable quantum dot (QD)-polypeptide hybrid assembly system with potential uses for both molecular imaging and delivery of biomolecular cargo to cancer cells. In this work, we...
10.
Hartmann L, Watanabe K, Zheng L, Kim C, Beck S, Huie P, et al.
J Biomed Mater Res B Appl Biomater
. 2011 Apr;
98(1):8-17.
PMID: 21504051
A novel interpenetrating network (IPN) based on poly(ethylene glycol) (PEG) and poly(acrylic acid) was developed and its use as an artificial cornea was evaluated in vivo. The in vivo results...